Gland Pharma launches cancer drug Bortezomib in US Ruchika Sharma5 May 2022 12:06 PM ISTHyderabad: Gland Pharma Limited, a generic injectable focused pharmaceutical company, through its partner has launched Bortezomib for Injection, 3.5 ...
Gilead, Dragonfly ink pact to develop natural killer cell engagers in oncology, inflammation Ruchika Sharma5 May 2022 9:15 AM ISTUnder the terms of the agreement, Gilead will make a $300 million upfront payment to Dragonfly.
Magnetic Therapy Enhances Chemotherapy Treatment of Breast Cancer Dr. Kamal Kant Kohli5 May 2022 9:00 AM ISTBreast cancer is the leading cause of cancer-associated death for women worldwide. While chemotherapy is the mainstream treatment for breast cancer,...
CT-detected emphysema associated with higher lung cancer risk Dr. Kamal Kant Kohli4 May 2022 9:30 PM ISTOAK BROOK, Ill: CT-detected emphysema is linked to a higher risk of lung cancer, a risk that increases with emphysema severity, according to a new...
Bayer gets USFDA priority review for darolutamide plus docetaxel to treat metastatic hormone-sensitive prostate cancer Ruchika Sharma4 May 2022 12:00 PM ISTDarolutamide is developed jointly by Bayer and Orion Corporation, a globally operating Finnish pharmaceutical company.
Aurobindo Pharma arm bags USFDA nod for cancer drug Bortezomib Ruchika Sharma4 May 2022 11:00 AM ISTHyderabad: Drugmaker, Aurobindo Pharma Limited, has recently announced that its wholly owned subsidiary company, Eugia Pharma Specialties...
Zydus Lifesciences bags USFDA nod for Bortezomib for Injection to treat cancer Ruchika Sharma3 May 2022 3:26 PM ISTThe drug will be manufactured at Zydus Hospira.
Regardless of Site, Newly Diagnosed Cancer Patients Are At Risk of CV Mortality MD Bureau3 May 2022 9:00 AM ISTCancer and cardiovascular (CV) disease share many risk factors, including smoking, lower socioeconomic status, and obesity. This suggests that...
Merck KEYTRUDA gets European nod to treat Deficient Mismatch Repair tumors Ruchika Sharma2 May 2022 1:00 PM ISTKEYTRUDA is an anti-programmed death receptor-1 (PD-1) therapy that works by increasing the ability of the body's immune system to help detect and...
Overdose of Chemotherapy: Senior Oncologist booked by CBI on death of Bahraini national Medical Dialogues Bureau2 May 2022 12:42 PM ISTOn March 15, 2016, the convicted accused Puthia Kovilakam, Prem Ravi Kumar, Senior Resident in Oncology Department, gave an order to dispense a dose...
New CAR T-cell therapy for solid tumors was safe and showed early efficacy Dr. Kamal Kant Kohli29 April 2022 9:00 AM ISTNEW ORLEANS: A new chimeric antigen receptor (CAR) T-cell product had an acceptable safety profile and showed early signs of efficacy as a monotherapy...
Less prostate cancer screening reduces overdiagnosis but may miss aggressive cases Dr. Kamal Kant Kohli28 April 2022 9:00 AM ISTOver the past 15 years, public health authorities have downgraded recommendations for the prostate-specific antigen (PSA) test as a screening tool to...
